Member Info for Serendipidity

What a bizarre LSE obsession this buy sell thing is. It’s a trade. Someone bought and someone sold. How it is marked is simply whether the price was above or below the mid at the time of the trade.

And back to 39p, sometimes it is better not to make finger in air predictions

SYME? The share that fell 40% last week due to yet more failed promises, and guff from AZ? I guess HEMO investors will feel at home there !!

* rub salt

There is a lot of wishful thinking going on today which is understandable. I am really not trying to run salt in the wounds as I was an investor and watched my profit go from 100% to zero, and I am considering jumping back in.

But Vlad has a serious credibility problem now (he had one before for me) and his claims of “The Company continues to work actively with GlobalCo in relation to development of the antibody” could be anything - a lab bench and an intern for 6 months? Whatever it is he will exaggerate it’s significance.

He is too emotionally involved in HEMO and inexperienced as a CEO to get the best deal for shareholders IMHO

Daft ramping does the share no favours. I may buy back in at 4.5 but won’t expect 7p for 3-6 months and that’s if some decent news comes out

Hat

That is fair however GCo knew the size of the market from the start

Commiserations to you lot. Vlad was the reason I sold out a while ago at evens, he’s probably a very bright scientist but
a hopeless CEO (can you imagine him negotiating with some big hitter in a globalco?).

People watching his Twitter feed and the price shooting up when he quotes a Louis Armstrong lyric tells you all. People can dress it up however they like but if CDX was a commercial winner the globalco (who know CDX inside out) would have made a competitive bid. Maybe they lowballed, maybe Vlad wanted too much but Ondint trust his judgement as he is too emotionally involved in HEMO to be rational, and a poor CEO.

JHFH - maybe change your name?

Thanks for the replies, I am topping up at anything under 40

@JetJock - HL really are useless

I never cease to be amazed by the irrelevance of a buy or sell label and the obsession on here with how they were assigned. Who cares whether the price was slightly above or below the mid?

Someone bought and someone sold, look at the price

I bought some no problem on IB at 41p, it’s your broker nothing sinister.

Any reason for the 4% fall back today?

If it’s suck an open secret would it not have been priced in already, in the recent sharp increase for example?
I hope you are right of course.

Agree Leem1, the SP is some seems to be getting way ahead of the recovery for some.

I sold today at 390 but think SAGA has a good medium and long term future, and will be one of the fitter survivors.

I have a GTC buy back trade set up already

So a midday trade reported after hours then

Spot on excessive

It was a trade, someone bought and someone sold, the price was below the mid at the time so it gets marked as a sell. So what? Don’t get the obsession between marking a trade as buy or a sell

So good to see DDDD awarding cheap shares to their II friends and a director. Good to see funds raised but a) did they really need to discount by 16%, and b) why weren’t PI given the opportunity to invest at the discounted price?

Still invested and positive but usual poor AIM behaviour

Hi
Looking to possibly invest but on which market? Should these roughly be in line or are not all shares equal in value?

UK ticker 88E.L 0.53p
US ticker EEENF 1.4 cents so 1.0p
ASX ticker 88E 1.1 cents so 0.6p

And moved down on the 9th, hence I don’t value a summit or conference as positive news at all. Interested in why others think it might be.

Genuine question - aside from a bit of PR why would those conferences move the SP in meaningful way?